science direct

Current sort has key articles at the top. Click on "Article Date" to sort by date, click on specific "tag" to view all articles in that category.

Title
Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study
01/15/2023

Our study showed that patients with medical cannabis authorization have a higher risk of emergency department visits or hospitalizations for depression compared to patients with no authorization. Our results also suggest that this risk is increased among patients without prior mental health disorders at cannabis authorization. The findings emphasize the need for a careful risk-benefit assessment that takes into account this observation prior to cannabis authorization. Further longitudinal


Medical, Psychosis, science direct
Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado
03/01/2022

Research has found that prenatal cannabis use may adversely affect fetal growth and neurodevelopment, be associated with future learning and behavioral problems in children, and increase risk of neonatal morbidity. (Cornelius et al., 2002; Day et al., 1994; El Marroun et al., 2011; Fried and Smith, 2001; Fried et al., 1999; Fried et al., 2003; Fried et al., 1997; Goldschmidt et al., 2000; Goldschmidt et al., 2008; Goldschmidt et al., 2012; Metz et al., 2017; Noland et al., 2005; Willford et al., 2010; Ryan et al., 2018; El Marroun et al., 2018) Several US organizations, including the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics, recommend abstinence from cannabis use during pregnancy. (Ryan et al., 2018; Gynecologists, T.A.C.O.O.A, 2020) Despite these recommendations, there are concerns that the trend of cannabis use during pregnancy will continue to increase as more states and countries legalize cannabis and allow for commercial sales through dispensaries. (Mark and Terplan, 2017)


Pregnancy, science direct, Research
Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?
02/05/2019

Two cases of sudden death are reported in patients whose self-determined seizure management primarily relied on artisanal cannabis therapies. Risks of morbidity, mortality and SUDEP in SDTC users need to be further studied. Providers should be aware of the absence of morbidity and mortality data for SDTC in patients with epilepsy may only be due to a failure of reporting.


epilepsy, science direct, Death
Cannabis use disorder and suicide attempts in Iraq/Afghanistan-era veterans
03/01/2017

This study of 3,233 veterans in a cross-sectional, multi-site study by the VA found that cannabis use disorder (CUD) was significantly associated with both current suicidal ideation and lifetime suicide attempts compared to veterans with no lifetime history of CUD.


Veterans, suicide, science direct
Subscribe to science direct